Evaluation of T-cell infiltrating lymphocytes vs. Th2 in triple negative breast cancers (TNBC)

被引:0
|
作者
Brousse, Susie
Godey, Florence
Laffont, Elodie
Tas, Patrick
Campillo-Gimenez, Boris
Lavoue, Vincent
Le Gallo, Matthieu
机构
关键词
D O I
10.1158/1538-7445.SABCS22-P2-11-23
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
P2-11-23
引用
收藏
页数:2
相关论文
共 50 条
  • [31] Neoadjuvant eribulin plus carboplatin vs. paclitaxel plus carboplatin in patients with triple-negative breast cancer (TNBC)
    Gigolaeva, L.
    Krivorotko, P.
    Khadzhimatova, S.
    Zhiltsova, E.
    Yerechshenko, S.
    Nikitina, M.
    Ni, V.
    Emelyanov, A.
    Imyanitov, E. N.
    Sokolenko, A. P.
    Tabagua, T.
    ANNALS OF ONCOLOGY, 2018, 29
  • [32] Clinical validity of compartmental analysis of tumor-infiltrating lymphocytes (TIL) in triple-negative breast cancer (TNBC) - The key is in spatial morphology?
    Vuger, Ana Tecic
    Separovic, Robert
    Vazdar, Ljubica
    Pavlovic, Mirjana
    Sitic, Sanda
    Belac-Lovasic, Ingrid
    Vrbanec, Damir
    CANCER RESEARCH, 2021, 81 (04)
  • [33] Prognostic value of histopathology, stromal tumor infiltrating lymphocytes (sTILs) and adjuvant chemotherapy (AdjCT) in early stage triple negative breast cancer (TNBC).
    Leon-Ferre, Roberto Antonio
    Polley, Mei-Yin
    Liu, Heshan
    Gilbert, Judith A.
    Cafourek, Victoria
    Hillman, David W.
    Elkhanany, Ahmed
    Akinhanmi, Margaret
    Negron, Vivian
    Boughey, Judy Caroline
    Liu, Minetta C.
    Ingle, James N.
    Kalari, Krishna R.
    Couch, Fergus
    Visscher, Daniel W.
    Goetz, Matthew P.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [34] Prognostic value of tumor infiltrating lymphocytes (TILs) on residual disease after primary chemotherapy for triple-negative breast cancer (TNBC) patients
    Dieci, M. V.
    Criscitiello, C.
    Guarneri, V.
    Conte, P. F.
    Goubar, A.
    Charpy, C.
    Viale, G.
    Delaloge, S.
    Curigliano, G.
    Andre, F.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S479 - S480
  • [35] Investigation of tumor infiltrating Lymphocytes of the Tumor Stroma (sTILs) in triple negative Breast Carcinomas (TNBC) from Sub-Saharan Africa (SAA)
    Bauer, M.
    Fathke, C.
    Stueckrath, K.
    Voigtlander, S.
    Vetter, M.
    Wickenhauser, C.
    Kantelhardt, E.
    GEBURTSHILFE UND FRAUENHEILKUNDE, 2020, 80 (10) : E94 - E94
  • [36] Predictive value of tumor-infiltrating lymphocytes to pathological complete response in neoadjuvant treated triple-negative breast cancers
    Ruan, Miao
    Tian, Tian
    Rao, Jia
    Xu, Xiaoli
    Yu, Baohua
    Yang, Wentao
    Shui, Ruohong
    DIAGNOSTIC PATHOLOGY, 2018, 13
  • [37] CD3+and FOXP3+Tumor-Infiltrating Lymphocytes Are Associated with Better Prognosis in Triple Negative Breast Cancers
    Iqbal, Jabed
    Yeong, Joe
    Lim, Jeffrey Chun Tatt
    Tan, Puay Hoon
    MODERN PATHOLOGY, 2016, 29 : 46A - 46A
  • [38] CD3+and FOXP3+Tumor-Infiltrating Lymphocytes Are Associated with Better Prognosis in Triple Negative Breast Cancers
    Iqbal, Jabed
    Yeong, Joe
    Lim, Jeffrey Chun Tatt
    Tan, Puay Hoon
    LABORATORY INVESTIGATION, 2016, 96 : 46A - 46A
  • [39] Predictive Value of Tumor-Infiltrating Lymphocytes to Pathological Complete Response in Neoadjuvant Treated Triple-Negative Breast Cancers
    Ruan, Miao
    Tian, Tian
    Rao, Jia
    Xu, Xiaoli
    Yu, Bao-Hua
    Yang, Wentao
    Shui, Ruohong
    LABORATORY INVESTIGATION, 2018, 98 : 102 - 102
  • [40] Predictive Value of Tumor-Infiltrating Lymphocytes to Pathological Complete Response in Neoadjuvant Treated Triple-Negative Breast Cancers
    Ruan, Miao
    Tian, Tian
    Rao, Jia
    Xu, Xiaoli
    Yu, Bao-Hua
    Yang, Wentao
    Shui, Ruohong
    MODERN PATHOLOGY, 2018, 31 : 102 - 102